SemioMVC Mosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector control
- Coordinator
- Molecular Attraction AB, Sweden
- Runs
- 1 December 2023 to 31 May 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €4.2m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190187847
What the project is doing
In the project's own words, from its summary on CORDIS.
Each year, chemicals worth €8bn are used for Mosquito Vector Control (MVC). Still, mosquito-borne diseases constitute a major socio-economic burden. As insecticides start losing efficacy and toxic chemicals are being banned from use (in the west in particular), we are becoming increasingly defenceless. By 2050, an additional 1bn people will be at risk of contracting at least one mosquito-borne disease due to the rapid expansion of habitats of mosquito vectors.
Molecular Attraction is a pioneer in mosquito-specific phagostimulants and pheromones. We can control mosquito behaviour using minute quantities of highly effective, affordable and perfectly green semiochemicals. In the project, we will conduct a large-scale trial in sub-Saharan Africa to evaluate the efficacy, cost-effectiveness and environmental impact of our unique blends. The trial results will be leveraged to enter the global MVC market.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Molecular Attraction AB | Nacka | Sweden | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI